HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. - Wikidata - awgldk - TriplyDB

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

http://www.wikidata.org/entity/Q51824401

about

Major clinical research advances in gynecologic cancer in 2013 American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.New strategies for human papillomavirus-based cervical screening Major clinical research advances in gynecologic cancer in 2014 Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer 3q26 amplification is an effective negative triage test for LSIL: a historical prospective study Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial.Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China.The dynamics of DNA methylation covariation patterns in carcinogenesis.Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening.[Computer-assisted diagnostics in cervical cytology].Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test.MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study.Major clinical research advances in gynecologic cancer in 2010 Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.Human papillomavirus testing in the prevention of cervical cancer Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia.Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array.Past and future of prophylactic ablation of the cervical squamocolumnar junction Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting.Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.

P2860

Q24562146-02C1723F-7468-4B6F-A634-12546AE17B13 Q24607403-D36E2AE7-9C8A-4389-9AF3-D456FC540A6C Q26824878-A9D4275F-28F0-4E51-8697-C4362D18AFF6 Q26828840-B789D797-2C01-4FBB-B2FF-5255EB9B0BC7 Q26851699-D887641F-4FF5-4808-A2B8-8EF3211EEC4E Q26992183-3E29FA60-20A6-4A64-9F03-50A6D658A9CE Q27023127-29CD132A-B1C1-4BFD-B4D5-7B6F21A6D14C Q28480584-79478B56-E694-4094-BD97-122B92B9DC1A Q28727452-2664BA21-929F-4CFA-B9C0-17A7FB2A7CD7 Q30651813-8B9236C7-EC27-445E-A4AD-E12764F5CEDF Q33518244-7C1BF54E-9657-42A9-9536-DB5F5D752A1E Q33669871-96FB3266-B046-4BC2-AA99-C67544D44BAC Q33746081-731966A3-0761-4BDC-AF64-FC7DBCBD21AB Q33760459-660B92F5-ACFD-49FA-89E2-ADC4B8DB9F6D Q33852568-846C6149-F597-4E4B-B162-DA3CF67F06F0 Q33853760-119327E5-87DC-4033-972F-4BA9747A1A09 Q33880743-A3C54FF0-EEAC-4BE6-BE15-435480060163 Q34059732-EB1456A1-B0EF-4607-8E63-02E52BE62D77 Q34061705-D80271C9-237D-4466-AA04-A8B95E4033F3 Q34079454-C98DB339-53D6-4678-BCEB-439A28D58739 Q34250191-26355CDF-F29B-4A44-93F2-C5832D03353C Q34299702-0048896C-BE59-44F1-AA0A-0FAF2691730C Q34515263-343B0388-5BB2-44AF-9D71-BCB86F4A87D6 Q34517694-9CA52545-B347-4C0F-82C3-27CAA10D75FC Q34608714-664F57CF-9864-4E1E-BEAA-88604FC3D825 Q34616083-668070E7-59DB-4CF9-9956-C845AC04C814 Q34850316-F07BD65B-1428-478B-8092-B23010D334B7 Q35036033-5410D104-8936-48BB-9744-97DF48BF2729 Q35117225-B9BC513B-D1A0-491F-8DDB-9BE64406B253 Q35182177-C9514494-2ED0-4212-8A6F-F97C71CA222D Q35203251-42DE8CE9-89B5-4A65-A528-E6F320799C7D Q35203306-CF0CC52A-504A-4A3F-9303-AC46A3A03B21 Q35324720-357C90B0-9718-4A07-BD12-DF727BB0A62E Q35550810-680DBCB6-B61B-4E33-8EBC-68BFDFFF3D90 Q35579691-0ED81012-E502-4C4F-AC27-38956EFA10F0 Q35605616-5BA1E066-B6D4-474C-A1ED-7D4035E457D2 Q35669010-5C25A1E3-24BE-4722-9881-B7D602E388EF Q35738881-47975D67-D031-4ECD-8397-767654FEFE07 Q35835143-B69B4C62-159C-4EC9-871D-4140E0CC468D Q35870574-17824789-F58C-4F9F-ACCA-65356F6F3949

P2860

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

http://www.wikidata.org/entity/Q51824401

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

HPV testing in combination wit ...... a randomised controlled trial.

@en

HPV testing in combination with liquid-based cytology in primary cervical screening

@nl

type

label

HPV testing in combination wit ...... a randomised controlled trial.

@en

HPV testing in combination with liquid-based cytology in primary cervical screening

@nl

prefLabel

HPV testing in combination wit ...... a randomised controlled trial.

@en

HPV testing in combination with liquid-based cytology in primary cervical screening

@nl

P1433

Q51824401-929AEA44-5154-49B3-A179-5DCDEC16A9DC

P1476

Q51824401-CBFC46E9-E0DA-4964-AA1F-393D9DC59F81

P2093

Q51824401-20E2BF5D-C516-4A94-8308-532F33E927ED

Q51824401-23DCED47-7E14-4754-8E90-506451362F02

Q51824401-27A7FD89-A9D7-469A-9424-43A0BC08A7A2

Q51824401-2F15162F-732C-4A77-B1F7-5912096D9945

Q51824401-306AFFF6-D10C-494D-AF3C-026027A43403

Q51824401-36192345-BA2F-402F-B84C-512D0082DA0D

Q51824401-58574492-2954-4D3E-8E7B-092529D1B127

Q51824401-5D14AB0E-F87A-463A-A583-E5DAB96E748C

Q51824401-8613AC48-95E9-40E1-91AE-6F1BF9EB0FED

Q51824401-8C2631DC-78C9-486D-8E98-B4A38ED340FE

P304

Q51824401-3EE0547A-BCE8-4B52-8881-76F10EC789AD

P31

Q51824401-58C7AF7F-DC32-4ECA-8980-180AA70F71B0

P356

Q51824401-F6E056CC-1A16-4B8B-8CDC-F7C4927CEBB2

P433

Q51824401-86B404CA-0A68-4EFC-80E8-B176F705DA2E

P478

Q51824401-16E982B8-5E33-43C9-9660-0A9CA64FE145

P50

Q51824401-2B7EA6B2-ACFF-4E00-9FC2-FE81CCF4BD2C

P577

Q51824401-1768ABD3-7BF2-40D7-93E6-AA807EC1CB76

P698

Q51824401-0506271E-B24E-400B-A3D6-6BD9D30D763B

P356

S1470-2045(09)70156-1

P1433

The Lancet Oncology

P1476

HPV testing in combination wit ...... a randomised controlled trial.

@en

P2093

Alexandra Sargent

http://www.w3.org/2001/XMLSchema#string

Andrew Bailey

http://www.w3.org/2001/XMLSchema#string

Andrew Turner

http://www.w3.org/2001/XMLSchema#string

Boyka Stoykova

http://www.w3.org/2001/XMLSchema#string

Christopher Roberts

http://www.w3.org/2001/XMLSchema#string

Claire Thomson

http://www.w3.org/2001/XMLSchema#string

Clare Gilham

http://www.w3.org/2001/XMLSchema#string

Helene Baysson

http://www.w3.org/2001/XMLSchema#string

Henry C Kitchener

http://www.w3.org/2001/XMLSchema#string

Jean Mather

http://www.w3.org/2001/XMLSchema#string

P304

672-682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1470-2045(09)70156-1

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19540162

http://www.w3.org/2001/XMLSchema#string